Equity (Tables)

6 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The following table sets forth stock-based compensation expense by award type:

	For the Three Months Ended March 31,				For the Six Months Ended March 31,
(in thousands)	2022		2021		2022		2021
Employee stock options	$	—	$	1	$	—	$	2
RSUs and RSAs	549		501		1,103		932
PSUs and PRSAs	487		269		894		586
ESPP	—		84		—		173
Outside director equity awards and fees in common stock	108		76		235		141
Total stock-based compensation expense	$	1,144	$	931	$	2,232	$	1,834

Schedule of Stock-based Compensation Expense - By Expense Type

The following table sets forth stock-based compensation expense by expense type:

	For the Three Months Ended March 31,				For the Six Months Ended March 31,
(in thousands)	2022		2021		2022		2021
Cost of revenue	$	178	$	203	$	329	$	344
Selling, general, and administrative	781		519		1,536		1,078
Research and development	185		209		367		412
Total stock-based compensation expense	$	1,144	$	931	$	2,232	$	1,834

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income per share:

	For the Three Months Ended March 31,				For the Six Months Ended March 31,
(in thousands, except per share data)	2022		2021		2022		2021
Numerator
Net (loss) income	$	(2,225)	$	4,384	$	189	$	6,953
Denominator
Weighted average number of shares outstanding - basic	37,217		32,968		37,082		31,219
Effect of dilutive securities
Stock options	—		6		4		2
PSUs, RSUs, and restricted stock	—		1,477		1,298		1,271
Weighted average number of shares outstanding - diluted	37,217		34,451		38,384		32,492
Earnings per share - basic	$	(0.06)	$	0.13	$	0.01	$	0.22
Earnings per share - diluted	$	(0.06)	$	0.13	$	0.01	$	0.21
Weighted average antidilutive options, unvested restricted RSUs and RSAs, unvested PSUs and ESPP shares excluded from the computation	75		1,536		72		1,331

Schedule of Common Stock Reserved for Future Issuances

As of March 31, 2022, we had common stock reserved for the following future issuances:

	Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options	13,884
Unvested RSUs and RSAs	2,445,307
Unvested PSUs and PRSAs (at 200% maximum payout)	4,098,106
Issuance of stock-based awards under the Equity Plans	312,137
Purchases under the officer and director share purchase plan	88,741
Total reserved	6,958,175